JOSHUA ATTIAS: Open Payments
NPI 1467124982 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,440 in 68 payments from 18 companies in 2025. Trend: 2023 $753 · 2024 $1,700 · 2025 $2,440
Food & beverage: $1,691Travel & lodging: $664Education: $85
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 5 | $1,157 |
| ABBVIE INC. | 17 | $316 |
| Incyte Corporation | 13 | $257 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $126 |
| Janssen Biotech, Inc. | 5 | $104 |
| PFIZER INC. | 4 | $82 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $68 |
| Lilly USA, LLC | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GENZYME CORPORATION | 1 | $43 |
Products named: Kerecis SurgiClose, OPZELURA, SKYRIZI, TREMFYA, CIBINQO, RINVOQ, TALTZ, DUPIXENT.
Industry payments across FL — which companies pay providers there.
